ST. LOUIS, Mo.—Patients with head and neck cancer have elevated treatment expenses for at least five years after diagnosis, according to a recently published study aimed at quantifying healthcare costs following this diagnosis (JAMA Otolaryngol Head Neck Surg 2022;10.1001/jamaoto.2022.3269).
“One thing that's been emerging in the last couple of decades in [head and neck cancer] is the rapid increase in the incidence of the cancer and the number of patients who are surviving